Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84


Return to normal life after AIDS as a reason for lost to follow-up in a community-based antiretroviral treatment program.

Alamo ST, Colebunders R, Ouma J, Sunday P, Wagner G, Wabwire-Mangen F, Laga M.

J Acquir Immune Defic Syndr. 2012 Jun 1;60(2):e36-45. doi: 10.1097/FTD.0b013e3182526e6a.


Socioeconomic support reduces nonretention in a comprehensive, community-based antiretroviral therapy program in Uganda.

Talisuna-Alamo S, Colebunders R, Ouma J, Sunday P, Ekoru K, Laga M, Wagner G, Wabwire-Mangen F.

J Acquir Immune Defic Syndr. 2012 Apr 1;59(4):e52-9. doi: 10.1097/QAI.0b013e318246e2aa.


Implementation and Operational Research: Early Tracing of Children Lost to Follow-Up From Antiretroviral Treatment: True Outcomes and Future Risks.

Ardura-Garcia C, Feldacker C, Tweya H, Chaweza T, Kalulu M, Phiri S, Wang D, Weigel R.

J Acquir Immune Defic Syndr. 2015 Dec 15;70(5):e160-7. doi: 10.1097/QAI.0000000000000772.


Male, mobile, and moneyed: loss to follow-up vs. transfer of care in an urban African antiretroviral treatment clinic.

Marson KG, Tapia K, Kohler P, McGrath CJ, John-Stewart GC, Richardson BA, Njoroge JW, Kiarie JN, Sakr SR, Chung MH.

PLoS One. 2013 Oct 24;8(10):e78900. doi: 10.1371/journal.pone.0078900. eCollection 2013.


Are they really lost? "true" status and reasons for treatment discontinuation among HIV infected patients on antiretroviral therapy considered lost to follow up in Urban Malawi.

Tweya H, Feldacker C, Estill J, Jahn A, Ng'ambi W, Ben-Smith A, Keiser O, Bokosi M, Egger M, Speight C, Gumulira J, Phiri S.

PLoS One. 2013 Sep 26;8(9):e75761. doi: 10.1371/journal.pone.0075761. eCollection 2013.


Self-transfer and mortality amongst adults lost to follow-up in ART programmes in low- and middle-income countries: systematic review and meta-analysis.

Wilkinson LS, Skordis-Worrall J, Ajose O, Ford N.

Trop Med Int Health. 2015 Mar;20(3):365-79. doi: 10.1111/tmi.12434. Epub 2015 Jan 6. Review.


Task-shifting to community health workers: evaluation of the performance of a peer-led model in an antiretroviral program in Uganda.

Alamo S, Wabwire-Mangen F, Kenneth E, Sunday P, Laga M, Colebunders RL.

AIDS Patient Care STDS. 2012 Feb;26(2):101-7. doi: 10.1089/apc.2011.0279. Epub 2012 Jan 6.


Temporal trends in mortality and loss to follow-up among children enrolled in Côte d'Ivoire's national antiretroviral therapy program.

Auld AF, Tuho MZ, Ekra KA, Shiraishi RW, Mohamed F, Kouakou JS, Ettiègne-Traoré V, Sabatier J, Essombo J, Rivadeneira ED, Adjorlolo-Johnson G, Marlink R, Ellerbrock TV.

Pediatr Infect Dis J. 2014 Nov;33(11):1134-40. doi: 10.1097/INF.0000000000000457.


Impact of definitions of loss to follow-up (LTFU) in antiretroviral therapy program evaluation: variation in the definition can have an appreciable impact on estimated proportions of LTFU.

Grimsrud AT, Cornell M, Egger M, Boulle A, Myer L.

J Clin Epidemiol. 2013 Sep;66(9):1006-13. doi: 10.1016/j.jclinepi.2013.03.013. Epub 2013 Jun 15.


Estimating loss to follow-up in HIV-infected patients on antiretroviral therapy: the effect of the competing risk of death in Zambia and Switzerland.

Schöni-Affolter F, Keiser O, Mwango A, Stringer J, Ledergerber B, Mulenga L, Bucher HC, Westfall AO, Calmy A, Boulle A, Chintu N, Egger M, Chi BH; Swiss HIV Cohort Study; IeDEA Southern Africa.

PLoS One. 2011;6(12):e27919. doi: 10.1371/journal.pone.0027919. Epub 2011 Dec 19.


Movement between facilities for HIV care among a mobile population in Kenya: transfer, loss to follow-up, and reengagement.

Hickey MD, Omollo D, Salmen CR, Mattah B, Blat C, Ouma GB, Fiorella KJ, Njoroge B, Gandhi M, Bukusi EA, Cohen CR, Geng EH.

AIDS Care. 2016 Nov;28(11):1386-93. doi: 10.1080/09540121.2016.1179253. Epub 2016 May 4.


Illicit drug use is a significant risk factor for loss to follow up in patients with HIV-1 infection at a large urban HIV clinic in Tokyo.

Nishijima T, Gatanaga H, Komatsu H, Takano M, Ogane M, Ikeda K, Oka S.

PLoS One. 2013 Aug 7;8(8):e72310. doi: 10.1371/journal.pone.0072310. eCollection 2013.


Outcomes and associated risk factors of patients traced after being lost to follow-up from antiretroviral treatment in Lilongwe, Malawi.

Weigel R, Hochgesang M, Brinkhof MW, Hosseinipour MC, Boxshall M, Mhango E, Nkwazi B, Tweya H, Kamlaka M, Chagwera F, Phiri S.

BMC Infect Dis. 2011 Jan 27;11:31. doi: 10.1186/1471-2334-11-31.


Patients who return to care after tracking remain at high risk of attrition: experience from a large HIV clinic, Uganda.

Nakiwogga-Muwanga A, Musaazi J, Katabira E, Worodria W, Talisuna SA, Colebunders R.

Int J STD AIDS. 2015 Jan;26(1):42-7. doi: 10.1177/0956462414529098. Epub 2014 Mar 19.


Aging and loss to follow-up among youth living with human immunodeficiency virus in the HIV Research Network.

Agwu AL, Lee L, Fleishman JA, Voss C, Yehia BR, Althoff KN, Rutstein R, Mathews WC, Nijhawan A, Moore RD, Gaur AH, Gebo KA.

J Adolesc Health. 2015 Mar;56(3):345-51. doi: 10.1016/j.jadohealth.2014.11.009.


The Majority of the Pre-Antiretroviral Population Who Were Lost to Follow-Up Stopped Their Care in Freetown, Sierra Leone: A 12-Month Prospective Cohort Study Starting with HIV Diagnosis.

Kelly JD, Schlough GW, Conteh S, Barrie MB, Kargbo B, Giordano TP.

PLoS One. 2016 Feb 22;11(2):e0149584. doi: 10.1371/journal.pone.0149584. eCollection 2016.


Tracing of patients lost to follow-up and HIV transmission: mathematical modeling study based on 2 large ART programs in Malawi.

Estill J, Tweya H, Egger M, Wandeler G, Feldacker C, Johnson LF, Blaser N, Vizcaya LS, Phiri S, Keiser O.

J Acquir Immune Defic Syndr. 2014 Apr 15;65(5):e179-86. doi: 10.1097/QAI.0000000000000075.


Not all are lost: interrupted laboratory monitoring, early death, and loss to follow-up (LTFU) in a large South African treatment program.

Ahonkhai AA, Noubary F, Munro A, Stark R, Wilke M, Freedberg KA, Wood R, Losina E.

PLoS One. 2012;7(3):e32993. doi: 10.1371/journal.pone.0032993. Epub 2012 Mar 12.


Implementation and operational research: evaluating outcomes of patients lost to follow-up in a large comprehensive care treatment program in western Kenya.

Rachlis B, Ochieng D, Geng E, Rotich E, Ochieng V, Maritim B, Ndege S, Naanyu V, Martin JN, Keter A, Ayuo P, Diero L, Nyambura M, Braitstein P.

J Acquir Immune Defic Syndr. 2015 Apr 1;68(4):e46-55. doi: 10.1097/QAI.0000000000000492.

Supplemental Content

Support Center